These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 29886488)

  • 41. Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results.
    Murthy R; Xiong H; Nunez R; Cohen AC; Barron B; Szklaruk J; Madoff DC; Gupta S; Wallace MJ; Ahrar K; Hicks ME
    J Vasc Interv Radiol; 2005 Jul; 16(7):937-45. PubMed ID: 16002501
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical efficacy of liver resection after downsizing systemic chemotherapy for initially unresectable liver metastases.
    Kawamura J; Yazawa T; Sumida K; Kida Y; Ogawa R; Tani M; Kawasoe J; Yamamoto M; Harada H; Yamamoto H; Zaima M
    World J Surg Oncol; 2016 Feb; 14():56. PubMed ID: 26911142
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A retrospective analysis of selective internal radiation therapy (SIRT) with yttrium-90 microspheres in patients with unresectable hepatic malignancies.
    Omed A; Lawrance JA; Murphy G; Laasch HU; Wilson G; Illidge T; Tipping J; Zivanovic M; Jeans S
    Clin Radiol; 2010 Sep; 65(9):720-8. PubMed ID: 20696299
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Selective transarterial radioembolisation of unresectable liver-dominant colorectal cancer refractory to chemotherapy.
    Golfieri R; Mosconi C; Giampalma E; Cappelli A; Galaverni MC; Pettinato C; Renzulli M; Monari F; Mazzarotto R; Pinto C; Angelelli B
    Radiol Med; 2015 Aug; 120(8):767-76. PubMed ID: 25678128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evidence-Based Integration of Yttrium-90 Radioembolization in the Contemporary Management of Hepatic Metastases from Colorectal Cancer.
    Wang DS; Louie JD; Sze DY
    Tech Vasc Interv Radiol; 2019 Jun; 22(2):74-80. PubMed ID: 31079714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selective internal radiation therapy with 90Y-SIR-Spheres microspheres for non-resectable colorectal metastases in the liver.
    Hadaki M; Praseedom R; Brais R; See TC; Balan K; Wilson CB
    BMJ Case Rep; 2011 May; 2011():. PubMed ID: 22696750
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of liver resection for colorectal cancer metastases in an era of multimodality treatment: a systematic review.
    Quan D; Gallinger S; Nhan C; Auer RA; Biagi JJ; Fletcher GG; Law CH; Moulton CA; Ruo L; Wei AC; McLeod RS;
    Surgery; 2012 Jun; 151(6):860-70. PubMed ID: 22316439
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Y90 selective internal radiation therapy.
    Lee EW; Thakor AS; Tafti BA; Liu DM
    Surg Oncol Clin N Am; 2015 Jan; 24(1):167-85. PubMed ID: 25444474
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment response in liver metastases following 90Y SIR-spheres: an evaluation with PET.
    Lin M; Shon IH; Wilson R; D'Amours SK; Schlaphoff G; Lin P
    Hepatogastroenterology; 2007; 54(75):910-2. PubMed ID: 17591090
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases.
    Cosimelli M; Golfieri R; Cagol PP; Carpanese L; Sciuto R; Maini CL; Mancini R; Sperduti I; Pizzi G; Diodoro MG; Perrone M; Giampalma E; Angelelli B; Fiore F; Lastoria S; Bacchetti S; Gasperini D; Geatti O; Izzo F;
    Br J Cancer; 2010 Jul; 103(3):324-31. PubMed ID: 20628388
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase II trial of selective internal radiation therapy and systemic chemotherapy for liver-predominant metastases from pancreatic adenocarcinoma.
    Gibbs P; Do C; Lipton L; Cade DN; Tapner MJ; Price D; Bower GD; Dowling R; Lichtenstein M; van Hazel GA
    BMC Cancer; 2015 Oct; 15():802. PubMed ID: 26503593
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mid-term results in otherwise treatment refractory primary or secondary liver confined tumours treated with selective internal radiation therapy (SIRT) using (90)Yttrium resin-microspheres.
    Jakobs TF; Hoffmann RT; Poepperl G; Schmitz A; Lutz J; Koch W; Tatsch K; Lubiensky A; Reiser MF; Helmberger T
    Eur Radiol; 2007 May; 17(5):1320-30. PubMed ID: 17149621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diffusion-weighted magnetic resonance imaging predicts survival in patients with liver-predominant metastatic colorectal cancer shortly after selective internal radiation therapy.
    Schmeel FC; Simon B; Sabet A; Luetkens JA; Träber F; Schmeel LC; Ezziddin S; Schild HH; Hadizadeh DR
    Eur Radiol; 2017 Mar; 27(3):966-975. PubMed ID: 27271923
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A pilot study of multimodality therapy for initially unresectable liver metastases from colorectal carcinoma: hepatic resection after hepatic arterial infusion chemotherapy and portal embolization.
    Akasu T; Moriya Y; Takayama T
    Jpn J Clin Oncol; 1997 Oct; 27(5):331-5. PubMed ID: 9390211
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    Kurilova I; Beets-Tan RGH; Ulaner GA; Boas FE; Petre EN; Yarmohammadi H; Ziv E; Deipolyi AR; Brody LA; Gonen M; Sofocleous CT
    Cardiovasc Intervent Radiol; 2018 Sep; 41(9):1419-1427. PubMed ID: 29766239
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Liver metastases from colorectal cancer: radioembolization with systemic therapy.
    Nicolay NH; Berry DP; Sharma RA
    Nat Rev Clin Oncol; 2009 Dec; 6(12):687-97. PubMed ID: 19884901
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiation microsphere-induced GI ulcers after selective internal radiation therapy for hepatic tumors: an underrecognized clinical entity.
    Konda A; Savin MA; Cappell MS; Duffy MC
    Gastrointest Endosc; 2009 Sep; 70(3):561-7. PubMed ID: 19577743
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Diagnosis and treatment of colorectal liver metastases - workflow].
    Grundmann RT; Hermanek P; Merkel S; Germer CT; Grundmann RT; Hauss J; Henne-Bruns D; Herfarth K; Hermanek P; Hopt UT; Junginger T; Klar E; Klempnauer J; Knapp WH; Kraus M; Lang H; Link KH; Löhe F; Merkel S; Oldhafer KJ; Raab HR; Rau HG; Reinacher-Schick A; Ricke J; Roder J; Schäfer AO; Schlitt HJ; Schön MR; Stippel D; Tannapfel A; Tatsch K; Vogl TJ;
    Zentralbl Chir; 2008 Jun; 133(3):267-84. PubMed ID: 18563694
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres.
    Lau WY; Kennedy AS; Kim YH; Lai HK; Lee RC; Leung TW; Liu CS; Salem R; Sangro B; Shuter B; Wang SC
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):401-7. PubMed ID: 20950954
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective internal radiation therapy (SIRT) with yttrium-90 microspheres for unresectable intrahepatic cholangiocarcinoma.
    Abeysinghe V; Sundararajan S; Delriviere L; Tibballs J
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29523614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.